Place of Origin : Hangzhou,China

By simulating the action of insulin-like peptide-1, blood glucose levels can be reduced, insulin secretion can be increased, gastrointestinal glucose absorption can be inhibited, and liver glucose production can be reduced. Smegglutide has also been studied for weight management. At higher doses, semaglutide has been developed as a drug for the treatment of obesity. This drug has performed well in clinical trials, with significant therapeutic effects and high safety